#MondayTips
Every Monday, WSA Social Media Leader Rodrigo Guerrero publishes a #MondayTip on the WSA WorldStrokeEd Twitter account, covering a specific stroke related topic. You can find a compilation of our #MondayTips here!
Every Monday, WSA Social Media Leader Rodrigo Guerrero publishes a #MondayTip on the WSA WorldStrokeEd Twitter account, covering a specific stroke related topic. You can find a compilation of our #MondayTips here!
#MondayTip
#Tenecteplase may help—even when the artery stays closed.
In #TRACE3 (4.5–24h window), pts without recanalization still had better outcomes (42% vs 30%). Strongest effect in NIHSS ≥10.
👉 Think beyond large vessel reopening
https://doi.org/10.1186/s12916-026-04877-x
#MondayTip
Can we prevent stroke without increasing bleeding?
Factor XIa inhibition #asundexian :
🔹⬇️recurrent stroke (HR 0.74)
🔸with no ⬆️major bleeding in OCEANIC-STROKE.
A potential shift in secondary prevention. 🧠⚖️
🔗 https://www.nejm.org/doi/full/10.1056/NEJMoa2513880
#MondayTip
#GFAP
📈Rises early in intracerebral hemorrhage (2–6h)🩸, but later in ischemic stroke (peak days 2–5)
💡Promising for early differentiation & triage
☝️but not ready as a standalone test
https://doi.org/10.3390/jcm14217748
#MondayTip
#Collaterals
Collateral status are relevant in stroke
🧠 Good collaterals + recanalization → strong outcomes
⚠️ Poor collaterals → limited benefit, even if opened
CTA isn’t just diagnostic—it’s decision-making
https://doi.org/10.3174/ajnr.a3817
#MondayTip
Cancer-related stroke ≠ routine ESUS
~50% of strokes in active cancer are cryptogenic, but many are cancer-driven hypercoagulable events
🔁14–29% recur at 1 year
⚖️Anticoag vs aspirin? Still equipoise
🧠Classify. Risk-stratify. Individualize
https://doi.org/10.1161/str.0000000000000517
#MondayTip
Hypoperfusion Intensity Ratio
#HIR may be the most practical collateral biomarker in AIS
⬆️High HIR (>0.4) → rapid core growth, ↑ hemorrhage risk, worse mRS.
⬇️Low HIR → robust collaterals & better EVT outcomes.
https://doi.org/10.3174/ajnr.A8557
Missed what happened in February at @WorldStrokeEd? 👀
Catch up with our monthly newsletter!
🎓 Upcoming & past webinars
🎙️ New podcast episodes
📊 Fresh infographics
💡 Latest #MondayTips by @interneurona
🤓 Read it here:
https://www.world-stroke-academy.org/news/february-newsletter-3/
#StrokeEducation #StrokeCare
#MondayTip
Not all “seizures” are epilepsy.
🧠 #LimbShakingTIA = hypoperfusion from carotid disease
📌 Triggered by standing/exertion
📉 EEG often normal
⚠️ Treat flow, not firing
https://doi.org/10.1136/pn-2025-004976
#MondayTip
New AHA dyslipidemia guides emphasizes earlier &➕ intensive LDL-C⬇️, often requiring non-statin therapy
PCSK9 options:
🧬Inclisiran (siRNA):↓PCSK9 production, dosing every 6m
💉Alirocumab/Evolocumab:✋circulating PCSK9
Both ↓LDL~50–60%, including in stroke patients
Missed what happened in February at @WorldStrokeEd? 👀
Catch up with our monthly newsletter!
🎓 Upcoming & past webinars
🎙️ New podcast episodes
📊 Fresh infographics
💡 Latest #MondayTips by @interneurona
🤓 Read it here:
https://www.world-stroke-academy.org/news/february-newsletter-3/
#StrokeEducation #StrokeCare
#MondayTip
#Stroke is not the same in #women and men
☝️Women have unique risk factors (pregnancy complications, menopause), are more likely to be misdiagnosed, rec&eive thrombolysis less often, despite similar benefit
Time for sex-responsive stroke care
https://doi.org/10.1177/17474930251393009
#MondayTip
Hypoperfusion Intensity Ratio
#HIR may be the most practical collateral biomarker in AIS
⬆️High HIR (>0.4) → rapid core growth, ↑ hemorrhage risk, worse mRS.
⬇️Low HIR → robust collaterals & better EVT outcomes.
https://doi.org/10.3174/ajnr.A8557
#MondayTip
Cancer-related stroke ≠ routine ESUS
~50% of strokes in active cancer are cryptogenic, but many are cancer-driven hypercoagulable events
🔁14–29% recur at 1 year
⚖️Anticoag vs aspirin? Still equipoise
🧠Classify. Risk-stratify. Individualize
https://doi.org/10.1161/str.0000000000000517
#MondayTip
Cancer-related stroke ≠ routine ESUS
~50% of strokes in active cancer are cryptogenic, but many are cancer-driven hypercoagulable events
🔁14–29% recur at 1 year
⚖️Anticoag vs aspirin? Still equipoise
🧠Classify. Risk-stratify. Individualize
https://doi.org/10.1161/str.0000000000000517
#MondayTIP
#FLAIR hyperintense vessels ≠ clot
🧩Hemodynamic clue!
🧠Distal FVH→collateral flow
⏱ Early window→possible viable penumbra
⚠️In TIA→ think persistent large-vessel stenosis
☝️Sometimes FLAIR tells you what perfusion can’t
🔎Look closely
https://bit.ly/4rntsAA
#MondayTip
#Tenecteplase may help—even when the artery stays closed.
In #TRACE3 (4.5–24h window), pts without recanalization still had better outcomes (42% vs 30%). Strongest effect in NIHSS ≥10.
👉 Think beyond large vessel reopening
https://doi.org/10.1186/s12916-026-04877-x
🎙️In the final episode of our Spasticity Unlocked series we shift the focus to what matters most: 𝐭𝐡𝐞 𝐩𝐚𝐭𝐢𝐞𝐧𝐭.
Dr. Stevens is joined by Gerard Sewell, offering a powerful & personal perspective on navigating life with #spasticity.
🔢Episodes: https://shorturl.at/F2QYE
#MondayTip
Can we prevent stroke without increasing bleeding?
Factor XIa inhibition #asundexian :
🔹⬇️recurrent stroke (HR 0.74)
🔸with no ⬆️major bleeding in OCEANIC-STROKE.
A potential shift in secondary prevention. 🧠⚖️
🔗 https://www.nejm.org/doi/full/10.1056/NEJMoa2513880
New #PaperOfTheMonth 🔍
🧠Stroke in people living with #HIV is rising & often underrecognized.
🧩A complex mix of
👉vasculopathy
👉inflammation
👉ART effects
👉and traditional risk factors is driving risk at younger ages
Read and listen here ⤵️
https://www.world-stroke-academy.org/news/the-paper-of-the-month-april-5/
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |